The store will not work correctly when cookies are disabled.
2-((((1r,4r)-4-hydroxycyclohexyl)thio)methyl)-8-methylquinazolin-4(3H)-one
ID: ALA5180051
PubChem CID: 138696699
Max Phase: Preclinical
Molecular Formula: C16H20N2O2S
Molecular Weight: 304.42
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cccc2c(=O)[nH]c(CS[C@H]3CC[C@H](O)CC3)nc12
Standard InChI: InChI=1S/C16H20N2O2S/c1-10-3-2-4-13-15(10)17-14(18-16(13)20)9-21-12-7-5-11(19)6-8-12/h2-4,11-12,19H,5-9H2,1H3,(H,17,18,20)/t11-,12-
Standard InChI Key: OSFGFBLRIXHPSO-HAQNSBGRSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
-3.2144 1.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4998 1.6496 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7880 1.2378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7880 0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4980 0.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2144 0.4089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0733 1.6504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3585 1.2377 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3585 0.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0733 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0733 2.4754 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3559 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3559 -0.8251 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.0705 -1.2377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4980 -0.8243 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7852 -0.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4998 -1.2377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4998 -2.0629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7852 -2.4754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0705 -2.0629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2144 -2.4754 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
1 6 1 0
6 5 2 0
3 7 1 0
8 7 1 0
9 8 1 0
10 9 2 0
4 10 1 0
7 11 2 0
9 12 1 0
12 13 1 0
14 13 1 1
5 15 1 0
16 14 1 0
17 16 1 0
18 17 1 0
19 18 1 0
20 19 1 0
14 20 1 0
18 21 1 6
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 304.42 | Molecular Weight (Monoisotopic): 304.1245 | AlogP: 2.77 | #Rotatable Bonds: 3 |
Polar Surface Area: 65.98 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.75 | CX Basic pKa: 5.36 | CX LogP: 2.11 | CX LogD: 2.13 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.91 | Np Likeness Score: -0.90 |
References
1. Nizi MG, Maksimainen MM, Lehtiö L, Tabarrini O.. (2022) Medicinal Chemistry Perspective on Targeting Mono-ADP-Ribosylating PARPs with Small Molecules., 65 (11.0): [PMID:35608571] [10.1021/acs.jmedchem.2c00281] |